Literature DB >> 7259221

Systemic lupus erythematosus occurring in a patient with epidermolysis bullosa acquisita.

A D Dotson, S S Raimer, T V Pursley, J Tschen.   

Abstract

A dystrophic bullous eruption that met all the criteria for epidermolysis bullosa acquisita (EBA) developed in a 19-year-old woman five years before the onset of clinical and serologic evidence of systemic lupus erythematosus (SLE). Electron microscopic studies of skin lesions both before and after the development of SLE were consistent with the previously reported electron microscopic findings in patients with EBA. Direct immunofluorescence microscopic studies done on bullae before and after the diagnosis of SLE showed linear depositions of immunoglobulin and complement; indirect immunofluorescence microscopic study findings consistently showed no abnormalities. These findings have been noted in other cases of EBA and may implicate autoimmune, immunologic factors in the pathogenesis of the disease process. To our knowledge, the finding of SLE in association with EBA has not been previously reported.

Entities:  

Mesh:

Year:  1981        PMID: 7259221

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  3 in total

Review 1.  Autoimmunity against type VII collagen in inflammatory bowel disease.

Authors:  Gheorghe Hundorfean; Markus F Neurath; Cassian Sitaru
Journal:  J Cell Mol Med       Date:  2010-10       Impact factor: 5.310

Review 2.  Neutrophilic skin lesions in autoimmune connective tissue diseases: nine cases and a literature review.

Authors:  Estelle Hau; Marie-Dominique Vignon Pennamen; Maxime Battistella; Anne Saussine; Maud Bergis; Benedicte Cavelier-Balloy; Michel Janier; Florence Cordoliani; Martine Bagot; Michel Rybojad; Jean-David Bouaziz
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

Review 3.  Humoral Epitope Spreading in Autoimmune Bullous Diseases.

Authors:  Dario Didona; Giovanni Di Zenzo
Journal:  Front Immunol       Date:  2018-04-17       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.